Trials / Terminated
TerminatedNCT00337272
Treating Chronic Insomnia in Breast Cancer Patients
Phase IV: Treatment of Chronic Insomnia in Patients With Breast Cancer Following Completion of Chemotherapy
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Accelerated Community Oncology Research Network · Academic / Other
- Sex
- Female
- Age
- 21 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to evaluate the effectiveness of ramelteon 8mgs in the treatment of insomnia in patients that have completed their first chemotherapy treatment for breast cancer.
Detailed description
Phase IV, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy of ramelteon 8mgs in the treatment of insomnia in patients with breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Placebo taken 30 minutes before bedtime days 1-28 of treatment period |
| DRUG | Ramelteon | 8 mgs daily for days 1-28 of treatment period |
Timeline
- Start date
- 2006-08-01
- Primary completion
- 2008-08-01
- Completion
- 2009-01-01
- First posted
- 2006-06-15
- Last updated
- 2011-08-22
- Results posted
- 2009-07-21
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00337272. Inclusion in this directory is not an endorsement.